Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Regorafenib Tablets

Approval Number

国药准字H20243570

Company山东齐鲁制药有限公司

Registration Date

July 23, 2024

Drug Information

Generic Name

瑞戈非尼片

Dosage Form

片剂

Strength

40mg（按C₂₁H₁₅ClF₄N₄O₃计）

Drug Type

化学药品

Registration Date

July 23, 2024

Company Information

Applicant Company

Company Name山东齐鲁制药有限公司

Company Address

山东省济南市高新区新泺大街317号

Manufacturing Company

Company Name山东齐鲁制药有限公司

Company Address

山东省济南市高新区旅游路8888号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

瑞戈非尼片 - NMPA 批准文号 | MedPath